0001144204-16-076353.txt : 20160120 0001144204-16-076353.hdr.sgml : 20160120 20160120172650 ACCESSION NUMBER: 0001144204-16-076353 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160120 DATE AS OF CHANGE: 20160120 EFFECTIVENESS DATE: 20160120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSGENOMIC INC CENTRAL INDEX KEY: 0001043961 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 911789357 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-255611 FILM NUMBER: 161351861 BUSINESS ADDRESS: STREET 1: 12325 EMMET ST CITY: OMAHA STATE: NE ZIP: 68164 BUSINESS PHONE: 4027385480 MAIL ADDRESS: STREET 1: 12325 EMMET STREET CITY: OMAHA STATE: NE ZIP: 68164 D 1 primary_doc.xml X0707 D LIVE 0001043961 TRANSGENOMIC INC 12325 EMMET STREET OMAHA NE NEBRASKA 68164 4024525400 DELAWARE None None Corporation true Paul Kinnon c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Executive Officer Director President, Chief Executive Officer, Interim Chief Financial Officer and Secretary, Director Leon F. Richards c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Executive Officer Chief Accounting Officer Robert M. Patzig c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Doit L. Koppler, II c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Mya Thomae c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Michael Luther c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Biotechnology Decline to Disclose 06b false 2016-01-08 false true true false 0 Craig-Hallum Capital Group LLC 121395 None None 222 SOUTH NINTH STREET, SUITE 350 MINNEAPOLIS MN MINNESOTA 55402 CA CALIFORNIA VA VIRGINIA false 2199676 2199676 0 false 5 140000 0 In addition to the above, for $50, the Company issued to Craig-Hallum Capital Group LLC a 5 year warrant to purchase up to 107,527 shares of common stock with an exercise price of $1.21 per share, which will be exercisable beginning on July 8, 2016. 0 false TRANSGENOMIC INC /s/ Leon Richards Leon Richards Chief Accounting Officer 2016-01-20